BDBM37531 (4-Methyl-quinazolin-2-yl)-[5-(tetrahydro-furan-2-ylmethyl)-1,4,5,6-tetrahydro-[1,3,5]triazin-2-yl]-amine::(4-methylquinazolin-2-yl)-[3-(tetrahydrofurfuryl)-2,4-dihydro-1H-s-triazin-6-yl]amine::4-methyl-N-[3-(2-oxolanylmethyl)-2,4-dihydro-1H-1,3,5-triazin-6-yl]-2-quinazolinamine::4-methyl-N-[3-(oxolan-2-ylmethyl)-2,4-dihydro-1H-1,3,5-triazin-6-yl]quinazolin-2-amine::MLS000075817::SMR000015033::cid_654280

SMILES Cc1nc(NC2=NCN(CC3CCCO3)CN2)nc2ccccc12

InChI Key InChIKey=WPMRGEVZGVFJJX-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 37531   

TargetHuntingtin(Homo sapiens (Human))
Columbia University Molecular Screening Center

Curated by PubChem BioAssay
LigandPNGBDBM37531((4-Methyl-quinazolin-2-yl)-[5-(tetrahydro-furan-2-...)
Affinity DataIC50: >8.00E+3nMAssay Description:The mutation underlying Huntington's disease is an expansion of a polyglutamine tract in the N-terminus of the protein huntingtin (htt). Under no...More data for this Ligand-Target Pair
In DepthDetails PCBioAssay